Oncorus

Oncorus

Oncorus

Oncorus is an early-stage biotechnology company developing a next-generation immunotherapy platform to treat cancer.
Founded
2015
Raised
$84.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$79,500,000
Venture capital (Series B) - 2019
Perceptive Advisors Cowen Healthcare Investments
£4,000,000
Venture capital (Series A) - 2016
Astellas Venture Management
Team Size
2
Employees
$79,500,000 Venture capital (Series B)
PE HUB

Oncorus scores $79.5 mln Series B

£4,000,000 Venture capital (Series A)
biospace , FinSMEs

Oncorus Announces Additional Series A Financing Support From Astellas Venture Management LLC

Funding Health